Skip to main content
SpringerLink
Log in

Erkrankungen des peripheren Nervensystems

  • Chapter
Neurologische Therapie

  • 137 Accesses

Zusammenfassung

Engpasssyndrome entstehen durch eine „relative Enge“, wenn ein Nerv durch eine vorgebildete physiologische Enge hindurchtreten muss und die abnormen Zug- und Druckbelastungen den Nerv an dieser Stelle besonders vulnerabel machen. Zusätzliche pathophysiologische Faktoren, wie entzündliche oder degenerative Prozesse, endokrinologisch bedingte Gewebezunahme (Hypothyreose, Akromegalie bei dem Karpaltunnelsyndrom!) spielen ebenso eine Rolle wie Narbenstrukturen, Traumafolgen (sog.„Ulnarisspätlähmungen“) oder Begleiterkrankungen wie eine Polyneuropathie. Engpasssyndrome treten in der Regel in der 2. Lebenshälfte auf. Die Diagnostik hat neben der Erhebung des klinischen Befundes einschließlich der Erfassung vegetativer Störungen (Ninhy-drin-Test) die Elektromyographie und Elektroneurographie zu umfassen, um seltene Innervationsanomalien nicht zu übersehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adour KK, Ruboyianes JM, Van Doersten PG et al. (1996) Bell’s palsy treatment with acyclovir and prednisone compared with prednisone alone; a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 105(5): 371–375

    PubMed  CAS  Google Scholar 

  • Agbogu BN, Stern BJ, Sewell C et al. (1995) Therapeutic considerations in patients with refractory neurosacroidosis. Arch Neurol 52:875–879

    Article  PubMed  CAS  Google Scholar 

  • Allen RD, Al Harbi IS, Clouston PD et al. (1997) Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 63:830–838

    Article  PubMed  CAS  Google Scholar 

  • Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(Suppl): 21–24

    Article  Google Scholar 

  • Azulay JP, Rihet P, Pouget J et al. (1997) Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 62(4): 391–394

    Article  PubMed  CAS  Google Scholar 

  • Backonja M, Beydoun A, Edwards KR et al. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomized controlled trial. JAMA 280(21): 1831–1836

    Article  PubMed  CAS  Google Scholar 

  • Barker FG, Janetta PJ, Bissonette DJ et al. (1995) Microvascular decompression for hemifacial spasm. J Neurosurg 82:201–210

    Article  PubMed  Google Scholar 

  • Berger AR, Herskovitz S, Scelsa S (1995) The restauration of IVIG efficacy by plasma exchange in CIDP. Neurology 45(8): 1628–1629

    PubMed  CAS  Google Scholar 

  • Bergethon PR, Sabin TD, Lewis D et al. (1996) Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 47:944–951

    PubMed  CAS  Google Scholar 

  • Beutner KR, Friedmann DJ, Forszpaniak C et al. (1995) Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39:1546–1553

    PubMed  CAS  Google Scholar 

  • Blumberg H, Griesser HJ, Hornayk M, (1991) Neurologische Aspekte der Klinik, Pathophysiologie und Therapie der sympathischen Reflexdystrophie (Kausalgie, M. Sudeck). Nervenarzt 62: 205–211

    PubMed  CAS  Google Scholar 

  • Blumberg H, Hoffmann U (1994) Zur Diagnostik der sympathischen Reflexdystrophie. Nervenarzt 65:370–374

    PubMed  CAS  Google Scholar 

  • Blume G, Pestronk A, Soodnough LT (1995) Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and iv cyclophosphamide. Neurology 45:1577–1580

    PubMed  CAS  Google Scholar 

  • Bolten CF, Young GB, Zochodne DW (1993) The neurological complication of sepsis. Ann Neurol 33:94–150

    Article  Google Scholar 

  • Brock M, Iprenburg M, Janz C (1994) Die endoskopische Behandlung des Karpaltunnelsyndroms. Dtsch Ärzteblatt 91: A 2848–2852

    Google Scholar 

  • Capsaicin Study Group (1991) Treatment of painful diabetic neuropathy with topical capsicain: a multicenter double-blind, vehicle-controlled study. Arch Intern Med 151:2225–2229

    Article  Google Scholar 

  • Chang MH, Chiang HT, Lee SSJ et al. (1998) Oral drug of choice in carpal tunnel syndrome. Neurology 51: 390–393

    PubMed  CAS  Google Scholar 

  • Choudhary PP, Hughes RA (1995) Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. QJM 88:493–502

    PubMed  CAS  Google Scholar 

  • Christina M (1999) Bell’s palsy and HSV-1 infection. Muscle Nerve 22:1476–1478

    Article  Google Scholar 

  • Cook D, Dalakas M, Galdi A et al. (1990) High-dose intravenous Immunglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 40:212–214

    PubMed  CAS  Google Scholar 

  • Cortet B, Flipo RM, Coquerelle P et al. (1997) Treatment of severe, relactant reflex sympathetic dystrophy: assessment of efficiacy and safety of the second generation biphosphonate Pamidronate. Clin Rheumatol 16: 51–56

    Article  PubMed  CAS  Google Scholar 

  • Dalakas MC, Quarles RH, Farrer RG et al. (1996) A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 40(5): 792–798

    Article  PubMed  CAS  Google Scholar 

  • Dammers JWHH, Veering MM (1999) Injection with methylprednisolone proximal to the carpal tunnel: Randomized double blind trial. Br Med J 319/7214: 884–886

    Article  Google Scholar 

  • Deutsche Neuro-AIDS-Arbeitsgemeinschaft DNAA (2000) Erkrankungen des peripheren Nervensystems und der Muskulatur bei der HIV-Infektion. Nervenarzt 71:442–450

    Article  Google Scholar 

  • Diabetes Control and Complication Trial (DCCT) Research Group (1995) Effect of intensive-diabetes treatment on nerve conduction in the diabetes control and complication trial. Ann Neurol 38: 869–880

    Article  Google Scholar 

  • Doss M, Verspohl F (1979) Therapie akuter hepatischer Porphyrien. Med Klin 74:1229–1245

    PubMed  CAS  Google Scholar 

  • Dtsch Ärzteblatt (2000) 97: B–876 (Heft 16)

    Google Scholar 

  • Dutch Guillain-Barré Study Group (1994) Treatment of the Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study Ann Neurol 35: 749–752

    Article  Google Scholar 

  • Dyck PJ, O’Brien PC, Oviatt KF (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11:136–141

    Article  PubMed  CAS  Google Scholar 

  • Dyck PJ, O’Brien P, Swanson C, Low P, Daube J (1985) Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology 35:1173–1176

    PubMed  CAS  Google Scholar 

  • Dyck PJ, Daube J, O’Brien P, Pineda A, Low P, Windebank A, Swanson C (1986) Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314:461–465

    Article  PubMed  CAS  Google Scholar 

  • Dyck PJ, Litchy WJ, Kratz KM et al. (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838–845

    Article  PubMed  CAS  Google Scholar 

  • Dyck P, Low PA, Windebank J et al. (1991) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325:1482–1486

    Article  PubMed  CAS  Google Scholar 

  • Ellis CM, Leary S, Payan J et al. (1999) Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 67:15–19

    Article  PubMed  CAS  Google Scholar 

  • Endtz LJ (1958) Complications nerveuses du traitement aurique. Aperçu des symptomes neurologiques et psychiatriques résultants du traitement par le BAL. Rev Neurol (Paris) 99: 395–410

    CAS  Google Scholar 

  • Ertas M, Sagdnyu A, Arac N et al. (1998) Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 75: 257–259

    Article  PubMed  CAS  Google Scholar 

  • Evans DAP, Manly KA, McKensick (1960) Genetic control of isonidazid metabolism in man. Br Med J II: 485

    Article  Google Scholar 

  • Fauci AS, Katz P, Haynes BF, Wolff SM (1979) Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301:235–238

    Article  PubMed  CAS  Google Scholar 

  • French Cooperative Group on Plasma Exchange and Guillain-Barré Syndrome (1987) Efficiency of plasma exchange in Guillain-Barré-syndrome: role of replacement fluids. Ann Neurol 22: 753–761

    Article  Google Scholar 

  • Galer BS, Rowbotham MC, Perander J, Friedmann E (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80(3): 533–538

    Article  PubMed  CAS  Google Scholar 

  • Gobelet C, Waldburger M, Meier JL (1992) The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain 48:171–175

    Article  PubMed  CAS  Google Scholar 

  • Good JL, Chehrenama M, Mayer RF, Koski CL (1998) Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology 51:1735–1738

    PubMed  CAS  Google Scholar 

  • Guillain-Barré-Syndrome Steroide Trial Group (1993) Double blind trial of intravenous methylprednisolone in Guillain-Barré-syndrome. Lancet 341: 586–590

    Google Scholar 

  • Gross WL (1995) Vaskulitiden. Neues zu Klassifikation, Pathogenese und Therapie. Dtsch Ärzteblatt 92/19: A 1372–1381

    Google Scholar 

  • Hahn AF, Bolton CF, Pillay N et al. (1996a) Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 119:1055–1066

    Article  PubMed  Google Scholar 

  • Hahn AF, Bolton CF, Zochodne D, Feasby TE (1996b) Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled cross-over study. Brain 119:1067–1077

    Article  PubMed  Google Scholar 

  • Harari D, Gibbert FB, Dick JPR, Sidey MC (1991) Plasma exchange in the treatment of Refsum’s disease (heredopathia atactica polyneuritiformis). J Neurol Neurosurg Psychiatry 54: 514–617

    Article  Google Scholar 

  • Haslbeck M (1993) Autonome Neuropathie beim Diabetes mellitus: Diagnostik — Therapie-Risiken. Z Gesamte Inn Med 48/3:162–176

    Google Scholar 

  • Hassenbusch SJ, Stanton-Hicks M, Schoppa D et al. (1996) Long term results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg 84:415–423

    Article  PubMed  CAS  Google Scholar 

  • Haupt WF, Rosenow F, van der Ven C et al. (1996) Sequential treatment of Guillain-Barré syndrome with extracorporal elimination and intravenous immunoglobulin. J Neurol Sci 137: 145–149

    Article  PubMed  CAS  Google Scholar 

  • Hennen G (1989) Physikalische Manahmen bei Polyneuropathien. Med Welt 40:973–976

    Google Scholar 

  • Hennen G, Scholz A, Jörg J (1990) Video-Biofeedback und Laufband bei der Therapie von Gangstrungen In: Wild K von, Janzik HH (Hrsg) Neurologische Frührehabilitation. Zuck-schwerdt, München, S 229–231

    Google Scholar 

  • Hoffmann WY (1992) Reanimation of the paralysed face. Otolaryngol Clin North Am 25: 649–667

    Google Scholar 

  • Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial of prednisone in acute polyneuropathy. Lancet II: 750–753

    Article  Google Scholar 

  • Hughes RAC, Swan AV, Cornblath DR et al. (1997) Randomised trial of plasma exchange, intravenous imunoglobulin, and combined treatments in Guillain-Barré-Syndrome (plasma exchange/Sandoglobulin). Guillain-Barré-Syndrome Trial Group. Lancet 349:225–230

    Article  Google Scholar 

  • Hund E (1999) Critical polyneuropathy. Anaesthesiol Intensivmed Notfallmed Schmerzther 34(6): 334–339

    Article  CAS  Google Scholar 

  • Hungerbühler JP, Meier C, Ronselle L, Quadri P, Bogousslavsky J (1985) Refsum’s disease management by diet and plasmaphoresis. Eur Neurol 24:153–159

    Article  PubMed  Google Scholar 

  • Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B (1994) Comparison of intravenous penicillin G and oral doxycyclin for treatment of Lyme neurobor-reliosis. Neurology 44/7:1203–1207

    Google Scholar 

  • Kelly JJ (1985) Peripheral neuropathies associated with monoclonal proteins: A clinical review. Muscle Nerv 8:138–150

    Article  Google Scholar 

  • Kumar K, Nath RK, Toth C (1997) Spinal cord stimulation is effective in the management of reflex sympathetic dystrophy. Neurosurgery 40: 503–508; discussion 508–9

    PubMed  CAS  Google Scholar 

  • Kyle RA (2000) The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy. Ann Oncol 11(Suppl 1): 55–58

    Article  PubMed  Google Scholar 

  • Leger JM, Younes Chennoufi AB, Chassande B et al. (1994) Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammo-pathy. J Neurol Neurosurg Psychiatry 57(Suppl 1): 46–49

    Article  PubMed  Google Scholar 

  • Manhattanakul W, Crawford TO, Griffin JW, Goldstein JM, Cornblath DR (1996) Treatment of chronic inflammatory demyelinating polyneuropathy with ciclosporin-A. J Neurol Neurosurg Psychiatry 60:185–187

    Article  Google Scholar 

  • Mariette X, Chastang C, Clavelou P et al. (1997) A randomised clinical trial comparing inter-feron-a and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. J Neurol Neurosurg Psychiatry 63:28–34

    Article  PubMed  CAS  Google Scholar 

  • Martina ISJ, van Doorn PA, Schmitz PIM et al. (1999) Chronic motor neuropathies: response to interferon-β1 a after failure of conventional therapies. J Neurol Neurosurg Psychiatry 66: 197–201

    Article  PubMed  CAS  Google Scholar 

  • Maschke M (1999) HIV-assoziierte neurologische Erkrankungen. Akt Neurol 26: 349–359

    Article  Google Scholar 

  • Mende D, Suchenwirth RMA (1990) Neurosarkoidose. Vergleichende Analyse des klinischen Profils anhand von 537 Beobachtungen aus der Weltliteratur bis 1963 und von 1976 bis 1988. Fortschr Neurol Psychiatr 58: 7–18

    Article  PubMed  CAS  Google Scholar 

  • Menger H, Lincke HO (1987) Verlauf konservativ behandelter, unter Antikoagulanzienthera-pie aufgetretener Femoralisparesen infolge retroperitonealer Blutungen. Akt Neurol 14: 117–121

    Article  Google Scholar 

  • Meucci N, Capellari A, Barbieri S et al. (1997) Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 63(6): 765–769

    Article  PubMed  CAS  Google Scholar 

  • Meucci N, Baldini L, Capellar A et al. (1999) Anti-myelin-associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy. Ann Neurol 46:119–122

    Article  PubMed  CAS  Google Scholar 

  • Miehlke A (1979) Fazialislähmungen. In: Berendes J, Link R, Zöllner F (Hrsg) HNO-Heilkunde in Praxis und Klinik. Thieme, Stuttgart, S 5 (21.1–21.66)

    Google Scholar 

  • Moore PM, Cupps TR (1983) Neurological complication of vasculitis. Ann Neurol 14:155–167

    Article  PubMed  CAS  Google Scholar 

  • Morello CM, Leckband SG, Stoner CP et al. (1999) Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159(16): 1931–1937

    Article  PubMed  CAS  Google Scholar 

  • Morrow MJ (2000) Bell’s palsy and herpes zoster oticus. Current treatment options in neurology 2(5): 407–416

    Article  PubMed  Google Scholar 

  • Oh SJ, LaGanke C, Claussen GC (2001) Sensory Guillain-Barré syndrome. Neurology 56/1: 82–86

    Google Scholar 

  • Parilla P, Ramirez P, Bueno FS et al. (1995) Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Surg 82: 825–828

    Article  Google Scholar 

  • Pestronk A, Lopate G, Kornberg AJ et al. (1994) Distal lower motor neuron syndrome with high-titer serum IgM anti GM 1 antibodies: Improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology 44/11:2027–2031

    Google Scholar 

  • Pestronk A (1998) Multifocal motor neuropathy: diagnosis and treatment. Neurology 51(6 Suppl 5): 22–24

    Google Scholar 

  • Pfeifer MA, Schumer MP, Gelber DA (1997) Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 46(Suppl 2): 582–589

    Google Scholar 

  • Pfeiffer G (1999) Dysautonomie bei Guillain-Barré-Syndrom. Nervenarzt 70: 136–148

    Article  PubMed  CAS  Google Scholar 

  • Pfister HW (1993) Lyme-Neuroborreliose (Bannwarth-Syndrom). In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer, Stuttgart, S 505–511

    Google Scholar 

  • Rauck RL, Eisenach JC, Jackson K et al. (1993) Epidural Clonidine treatment for refractory reflex sympathetic dystrophy (see comments). Anesthesiology 79: 1163–1169; discussion 27 A

    Article  PubMed  CAS  Google Scholar 

  • Rees JH, Gregson NA, Hughes RAC (1995) Antiganglioside GM1 antibodies in Guillain-Barré-syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 38: 809–816

    Article  PubMed  CAS  Google Scholar 

  • Reichard P, Pihl M, Rosenquist U, Sule J (1996) Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow-up. Diabetologia 39: 1483–1488

    Article  PubMed  CAS  Google Scholar 

  • Reljanovic M, Reichel G, Rett K et al. (1999) Treatment of diabetic polyneuropathy with antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 31(3): 171–179

    Article  PubMed  CAS  Google Scholar 

  • Robotham M, Harden N, Stacy B et al. (1998) Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280(21): 1837–1842

    Article  Google Scholar 

  • Sanchorawala V, Wright DG, Dember LM et al. (1999) Five years experience with high dose intravenous Melphalan and autologous peripheral blood stem cell transplantation for the treatment of patients with Amyloidosis (Abstr). Blood 94(Suppl 1): 396a

    Google Scholar 

  • Schlegel U (1987) Neurosarkoidose: Diagnostik und Therapie. Fortschr Neurol Psychiatr 55: 1–15

    Article  PubMed  CAS  Google Scholar 

  • Simon C, Stille W (1997) Antibiotika-Therapie in Klinik und Praxis, 9. Aufl. Schattauer, Stuttgart New York

    Google Scholar 

  • Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83(3): 389–400

    Article  PubMed  CAS  Google Scholar 

  • Skinner M, Anderson J, Simms R et al. (1996) Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine only. Am J Med 100(3): 290–298

    Article  PubMed  CAS  Google Scholar 

  • Skodda S, Splitter JF, Gehlen W (1999) Parenterale Ganciclovir-Therapie bei einer immunkompetenten Patientin mit zytomegalievirusassoziiertem Guillain-Barré-Syndrom. Akt Neurol 26: 327–329

    Article  Google Scholar 

  • Sokol RJ, Guggenheim M, Jannaccone ST (1985) Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis. N Engl J Med 313:1580–1586

    Article  PubMed  CAS  Google Scholar 

  • Stangel M, Hartung HP, Marx P, Gold R (1998) Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 153:203–214

    Article  PubMed  CAS  Google Scholar 

  • Stöhr M (1998) Nerven — und Plexuslsionen nach Strahlentherapie. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 2. Aufl. Kohlhammer, Stuttgart, S 1094–1096

    Google Scholar 

  • Storstein A, Vedeler C (2001) Neuropathy and malignancy: a retrospective survey. J Neurol 248: 322–327

    Article  PubMed  CAS  Google Scholar 

  • Swash M, Schwartz MS (1990) Paraneoplastic syndrome. In: Johnson RT (ed) Current therapy in neurologic disease. Decker, Philadelphia Toronto, pp 236–243

    Google Scholar 

  • Tajti J, Szok D, Vecsei L (1999) Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia: results of a double blind comparative clinical trial. Neurobiology (Bp) 7(2): 103–108

    CAS  Google Scholar 

  • Thomas PK (1997) Tropical neuropathies. J Neurol 244:475–482

    Article  PubMed  CAS  Google Scholar 

  • van den Berg LH, Franssen H, Wokke JH (1998) The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 121(Pt 3): 421–428

    Article  PubMed  Google Scholar 

  • van der Meché FGA, Schmitz PI (1992) A randomized trial comparing intravenous immun globulin and plasma exchange in Guillain-Barré syndrome (The Dutch Guillain-Barré Study Group). N Engl J Med 326:1123–1129

    Article  PubMed  Google Scholar 

  • van Doorn, Brand A, Strengers PF et al. (1990) High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelination polyneuropathy: a double blind, placebo-controlled, crossover study. Neurology 40:209–212

    PubMed  Google Scholar 

  • Vermeulen M, Doorn PA van, Brand A, Strengers PF, Jennekens, Busch HF (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled study. J Neurol Neurosurg Psychiatr 56: 36–39

    Article  PubMed  CAS  Google Scholar 

  • Visser LH, Schmitz PI, Meulstee J et al. (1999) Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group. Neurology 53(3): 598–604

    PubMed  CAS  Google Scholar 

  • Weder B, Meienberg O, Wildi E, Meier C (1984) Neurologic disorder of vitamin E deficiency in acquired intestinal malabsorption. Neurology 34:1561–1565

    PubMed  CAS  Google Scholar 

  • Winkelmann J, Trenkwalder C (2000) Therapie des Restless-legs-Syndroms. Akt Neurol 27: 182–186

    Article  Google Scholar 

  • Wollinsky KH, Hülser PJ, Brinkmeier H, Mehrkens HH, Kornhuber HH, Rüdel R (1994) Konzept und therapeutische Effizienz der CSF — Filtration beim akuten Guillain-Barré-Syndrom. Symposium „CSF-Filtration“, Magdeburg, 11.06.94

    Google Scholar 

  • Wutzier P, Doerr HW (1998): Antivirale Therapie des Zoster. Dtsch Ärzteblatt 91:95–99

    Google Scholar 

  • Ziegler D, Hanefeld M, Ruhnau KJ et al. (1995) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoid acid. A 3-week multicenter randomized controlled trial (ALADIN Study). Diabetologia 38(12): 1425–1433

    Article  PubMed  CAS  Google Scholar 

  • Ziegler D, Hanefeld M, Ruhnau KJ (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic Acid in Diabetic Neuropathy. Diabetes Care 22(8): 1296–1301

    Article  PubMed  CAS  Google Scholar 

  • Zuurmond WW, Langendijk PN, Bezemer PD et al. (1996) Treatment of acute reflex sympathetic dystrophy with DMSO 50% in fatty cream. Acta Anaesthesiol Scand 40:364–367

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik der Universität Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Deutschland

    G. Hennen (Dr.) & J. Jörg (Prof. Dr.)

Authors
  1. G. Hennen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Jörg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Universität Witten/Herdecke, Heusnerstr. 40, 44283, Wuppertal

    Johannes Jörg

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag, Berlin Heidelberg

About this chapter

Cite this chapter

Hennen, G., Jörg, J. (2002). Erkrankungen des peripheren Nervensystems. In: Jörg, J. (eds) Neurologische Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56398-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56398-0_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67246-3

  • Online ISBN: 978-3-642-56398-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation